Stay updated with breaking news from Confidence Interval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. Our episode is live! Episode Description In this episode, we begin by discussing our article of the week which comes from
1. In this randomized controlled trial, doxycycline post-exposure prophylaxis (PEP) did not significantly reduce the risk of bacterial sexually transmitted infections (STIs) compared to standard care. 2. Doxycycline testing using hair indicated low protocol adherence by study participants. Evidence Rating Level: 1 (Excellent) Study Rundown: The incidence of bacterial STIs is increasing worldwide, prompting investigation
1. In this randomized-controlled trial, the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide reduced the risk of cardiovascular death, myocardial infarction, and stroke in obese patients without diabetes. 2. Semaglutide was associated with a higher risk of adverse events resulting in discontinuation compared to placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Obesity is an emerging
1. In this randomized controlled trial, percutaneous coronary intervention (PCI) resulted in decreased symptoms compared to a placebo procedure in patients with stable angina. 2. The incidence of serious adverse events was comparable for both groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Angina is often one of the first discernible symptoms of underlying coronary
1. In this randomized controlled trial, the Janus kinase (JAK) inhibitor baricitinib was associated with preserved β-cell function compared to placebo in patients with new-onset type 1 diabetes mellitus (T1DM). 2. Patients receiving baricitinib also demonstrated tighter glycemic control compared to placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: The mainstay of T1DM treatment is